Summerfelt AT - Search Results

1

Impaired Wisconsin Card Sort performance in schizophrenia may reflect motivational deficits.

Summerfelt AT, Alphs LD, Funderburk FR, Strauss ME, Wagman AM. Summerfelt AT, et al. Arch Gen Psychiatry. 1991 Mar;48(3):282-3. doi: 10.1001/archpsyc.1991.01810270094019. Arch Gen Psychiatry. 1991. PMID: 1996924 No abstract available.

2

Reduction of perseverative errors in patients with schizophrenia using monetary feedback.

Summerfelt AT, Alphs LD, Wagman AM, Funderburk FR, Hierholzer RM, Strauss ME. Summerfelt AT, et al. J Abnorm Psychol. 1991 Nov;100(4):613-6. doi: 10.1037//0021-843x.100.4.613. J Abnorm Psychol. 1991. PMID: 1757677

3

The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia.

Alphs LD, Summerfelt A, Lann H, Muller RJ. Alphs LD, et al. Psychopharmacol Bull. 1989;25(2):159-63. Psychopharmacol Bull. 1989. PMID: 2602512 No abstract available.

4

Rating affective flattening from videotaped interviews.

Waltrip RW 2nd, Strauss ME, Summerfelt A, Heinrichs D, Kirkpatrick B, Jauch D, Oltmanns TF. Waltrip RW 2nd, et al. Psychiatry Res. 1989 Feb;27(2):199-205. doi: 10.1016/0165-1781(89)90135-2. Psychiatry Res. 1989. PMID: 2710865

5

Carbamazepine maintenance treatment in outpatient schizophrenics.

Carpenter WT Jr, Kurz R, Kirkpatrick B, Hanlon TE, Summerfelt AT, Buchanan RW, Waltrip RW, Breier A. Carpenter WT Jr, et al. Among authors: summerfelt at. Arch Gen Psychiatry. 1991 Jan;48(1):69-72. doi: 10.1001/archpsyc.1991.01810250071010. Arch Gen Psychiatry. 1991. PMID: 1670617 Clinical Trial.

6

Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, Wonodi I, Buchanan RW, Myers C, Heishman SJ, Yang J, Nye A. Hong LE, et al. Arch Gen Psychiatry. 2011 Dec;68(12):1195-206. doi: 10.1001/archgenpsychiatry.2011.83. Epub 2011 Aug 1. Arch Gen Psychiatry. 2011. PMID: 21810630 Free PMC article. Clinical Trial.

7

Borna disease virus and schizophrenia.

Waltrip RW 2nd, Buchanan RW, Summerfelt A, Breier A, Carpenter WT Jr, Bryant NL, Rubin SA, Carbone KM. Waltrip RW 2nd, et al. Psychiatry Res. 1995 Jan 31;56(1):33-44. doi: 10.1016/0165-1781(94)02600-n. Psychiatry Res. 1995. PMID: 7792340

8

Continuous versus targeted medication in schizophrenic outpatients: outcome results.

Carpenter WT Jr, Hanlon TE, Heinrichs DW, Summerfelt AT, Kirkpatrick B, Levine J, Buchanan RW. Carpenter WT Jr, et al. Among authors: summerfelt at. Am J Psychiatry. 1990 Sep;147(9):1138-48. doi: 10.1176/ajp.147.9.1138. Am J Psychiatry. 1990. PMID: 1974743 Clinical Trial.

9

Borna disease virus antibodies and the deficit syndrome of schizophrenia.

Waltrip RW 2nd, Buchanan RW, Carpenter WT Jr, Kirkpatrick B, Summerfelt A, Breier A, Rubin SA, Carbone KM. Waltrip RW 2nd, et al. Schizophr Res. 1997 Feb 28;23(3):253-7. doi: 10.1016/s0920-9964(96)00114-4. Schizophr Res. 1997. PMID: 9075304

10

Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.

Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Lann HD, Breier AF, Summerfelt AT. Carpenter WT Jr, et al. Among authors: summerfelt at. Am J Psychiatry. 1999 Mar;156(3):412-8. doi: 10.1176/ajp.156.3.412. Am J Psychiatry. 1999. PMID: 10080557 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters